FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
64 hedge funds and large institutions have $288M invested in Flexion Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
28
Reduced
16
Closed
14
Calls
$4.67M
Puts
$1.03M
Net Calls
+$3.64M
Net Calls Change
-$1.14M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$10.1M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.02M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$2.83M |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.18M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.9M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$15.4M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.8M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$3.95M |
| 4 |
Morgan Stanley
New York
|
-$2.67M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.06M |
